HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor

Por Mekkawy, Ahmed H., Morris, David L., Pourgholami, Mohammad H.
Publicado em 2012

Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Viv...

Por Ataie-Kachoie, Parvin, Morris, David L., Pourgholami, Mohammad H.
Publicado em 2013

Peritoneal mesothelioma in a woman who has survived for seven years: a case report

Por Pillai, Krishna, Akhter, Javed, Pourgholami, Mohammad H, Morris, David L
Publicado em 2011

Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer

Por Bahrami, Farnaz, Morris, David L, Rufener, Lucien, Pourgholami, Mohammad H
Publicado em 2014

Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application

Por Amini, Afshin, Masoumi Moghaddam, Samar, Morris, David L., Pourgholami, Mohammad H.
Publicado em 2012

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

Por Masoumi Moghaddam, Samar, Amini, Afshin, Morris, David L., Pourgholami, Mohammad H.
Publicado em 2011

Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma?

Por Pillai, Krishna, Pourgholami, Mohammad H, Chua, Terence C, Morris, David L
Publicado em 2013

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma

Por Pillai, Krishna, Pourgholami, Mohammad H, Chua, Terence C, Morris, David L
Publicado em 2013

Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model

Por Noorani, Lubna, Stenzel, Martina, Liang, Roger, Pourgholami, Mohammad H, Morris, David L
Publicado no J Nanobiotechnology (2015)

Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR/p70S6K signalling pathway

Por Bahrami, Farnaz, Pourgholami, Mohammad H, Mekkawy, Ahmed H, Rufener, Lucien, Morris, David L
Publicado em 2014

Minocycline attenuates hypoxia-inducible factor-1α expression correlated with modulation of p53 and AKT/mTOR/p70S6K/4E-BP1 pathway in ovarian cancer: in vitro and in vivo studies

Por Ataie-Kachoie, Parvin, Pourgholami, Mohammad H, Bahrami-B, Farnaz, Badar, Samina, Morris, David L
Publicado no Am J Cancer Res (2015)

Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazole

Por Pourgholami, Mohammad H, Cai, Zhao Y, Badar, Samina, Wangoo, Kiran, Poruchynsky, Marianne S, Morris, David L
Publicado em 2010

Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in vivo Ovarian Cancer Model

Por Wang, Li, Chen, Hongmin, Pourgholami, Mohammad H., Beretov, Julia, Hao, Jingli, Chao, Hongtu, Perkins, Alan C., Kearsley, John H., Li, Yong
Publicado em 2011

A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Ac...

Por Kast, Richard E., Boockvar, John A., Brüning, Ansgar, Cappello, Francesco, Chang, Wen-Wei, Cvek, Boris, Dou, Q. Ping, Duenas-Gonzalez, Alfonso, Efferth, Thomas, Focosi, Daniele, Ghaffari, Seyed H., Karpel-Massler, Georg, Ketola, Kirsi, Khoshnevisan, Alireza, Keizman, Daniel, Magné, Nicolas, Marosi, Christine, McDonald, Kerrie, Muñoz, Miguel, Paranjpe, Ameya, Pourgholami, Mohammad H., Sardi, Iacopo, Sella, Avishay, Srivenugopal, Kalkunte S., Tuccori, Marco, Wang, Weiguang, Wirtz, Christian R., Halatsch, Marc-Eric
Publicado em 2013